UNDERSTANDING CLINICAL OUTCOMES IN PATIENTS RENDERED NO EVIDENCE OF DISEASE IN METASTATIC RENAL CELL CARCINOMA

被引：0
|
作者：
Oparanozie, Arnold
Reese, Stephen W.
Eismann, Lennert
Vasquez-Rivera, Katiana
Motzer, Robert
Voss, Martin H.
Lee, Chung-Han
Carlo, Maria
Kotecha, Ritesh R.
Coleman, Jonathan
Russo, Paul
Hakimi, A. Ari
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP64-20
引用
收藏
页码：E889 / E889
页数：1
相关论文
共 50 条
  • [21] Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma
    Tripathi, Rekha T.
    Heilbrun, Lance K.
    Jain, Vikash
    Vaishampayan, Ulka N.
    UROLOGY, 2006, 68 (02) : 296 - 301
  • [22] Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab
    Zahoor, Haris
    Barata, Pedro C.
    Jia, Xuefei
    Martin, Allison
    Allman, Kimberly D.
    Wood, Laura S.
    Gilligan, Timothy D.
    Grivas, Petros
    Ornstein, Moshe C.
    Garcia, Jorge A.
    Rini, Brian I.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [23] Metastatic Renal Cell Carcinoma (mRCC) Clinical Evidence and Quality of Supply in Germany
    Krause, Andreas
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (12) : 795 - 795
  • [24] Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
    Loukas F Kontovinis
    Konstantinos T Papazisis
    Panagiota Touplikioti
    Charalambos Andreadis
    Despoina Mouratidou
    Alexandros H Kortsaris
    BMC Cancer, 9
  • [25] Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
    Kontovinis, Loukas F.
    Papazisis, Konstantinos T.
    Touplikioti, Panagiota
    Andreadis, Charalambos
    Mouratidou, Despoina
    Kortsaris, Alexandros H.
    BMC CANCER, 2009, 9
  • [26] Metastatic renal cell carcinoma without evidence of a renal primary
    Corey Costantino
    George V. Thomas
    Christopher Ryan
    Fergus V. Coakley
    Megan L. Troxell
    International Urology and Nephrology, 2016, 48 : 73 - 77
  • [27] Metastatic renal cell carcinoma without evidence of a renal primary
    Costantino, Corey
    Thomas, George V.
    Ryan, Christopher
    Coakley, Fergus V.
    Troxell, Megan L.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (01) : 73 - 77
  • [28] Stabilization of disease in patients with metastatic renal cell carcinoma using sorafenib
    Brian I Rini
    Nature Clinical Practice Oncology, 2006, 3 : 602 - 603
  • [29] Stabilization of disease in patients with metastatic renal cell carcinoma using sorafenib
    Rini, Brian I.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (11): : 602 - 603
  • [30] Proton Pump Inhibitors and Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma
    Lalani, Aly-Khan A.
    McKay, Rana R.
    Lin, Xun
    Simantov, Ronit
    Kaymakcalan, Marina D.
    Choueiri, Toni K.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (06) : 724 - 732
12345